GHK-Cu's collagen stimulation and skin repair claims are supported by active Phase II and completed Phase IV human clinical trials specifically testing these endpoints—a credible evidence tier. Anti-inflammatory properties and 'overall recovery' lack direct scientific support in the current literature. The strongest claims (collagen, skin repair) have human trials actively enrolled or completed, making them the most scientifically grounded among bioregulatory peptides in this category.
Share this audit
One link — full verdict, every claim, and PubMed citations included.
Shareable link includes the full verdict, claims, and PubMed citations.
Post captionshow
what to know
Video transcriptshow
If you're on Reddit right now and you're starting to see body composition changes, here's why. This is the exact time that a lot of people add GHKCU to their stack. These two compounds seem totally different on surface level. One's metabolic and one's for skin and heal, but they actually compliment each other really well. Because you see, when you're in a calorie deficit on Reddit, your skin can l…
Show full video transcript
ose some elasticity city and collagen as you lean out. G H K C U. Directly addresses that by stimulating collagen production and supporting skin repair. G H K C U. Also has anti inflammatory properties that help overall recovery, which matters more when you're in a deficit and still training. The result is that people running both tend to look better as they lean out. The skin in quality changes keep pace with the body composition changes. This isn't an essential stack, but it's a smart one if aesthetics beyond the scale matter to you. Cheat sheets for both are in my bio with a full protocol breakdown. Just be consistent with both and give both time to do their job.
Show lessClaim breakdown
4 claims“GHKCU stimulates collagen production.”
Human Phase IV trial (NCT05932732, completed) and active Phase II randomized controlled trial (NCT07437586) directly testing topical GHK-Cu for skin quality and wound re-epithelialization provide direct clinical evidence. PeptIQ internal FAQ confirms foundational fibroblast and wound model research documenting GHK-Cu stimulation of collagen types I and III—supporting the claim's mechanistic direction.
“GHKCU supports skin repair.”
Active Phase II randomized controlled trial (NCT07437586) specifically tests topical GHK-Cu gel for accelerated re-epithelialization of acute skin wounds in healthy adults, directly addressing skin repair. Completed Phase IV trial (NCT05932732) assessed skin quality and barrier function, both consistent with repair mechanisms.
Supporting studies
“GHKCU has anti-inflammatory properties.”
No human clinical trials registered for GHK-Cu and anti-inflammatory properties specifically. No PubMed abstracts retrieved for this claim. While PeptIQ internal context mentions TB-500 and BPC-157 have anti-inflammatory research, no direct evidence for GHK-Cu anti-inflammatory activity was found in this search.
“GHKCU helps overall recovery.”
No human clinical trials registered for GHK-Cu and 'overall recovery' broadly. No PubMed abstracts retrieved. The existing trials focus on skin repair and collagen/skin quality—specific mechanistic endpoints—not systemic recovery or general wellness.
This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.
Report an error